Original Research
Published on 16 Oct 2025
BYS10, a novel selective RET inhibitor, exhibits potent antitumor activity in preclinical models
in Pharmacology of Anti-Cancer Drugs
- 1,759 views
- 1 citation
Original Research
Published on 16 Oct 2025
in Pharmacology of Anti-Cancer Drugs
Review
Published on 04 Dec 2018
in Ethnopharmacology
Original Research
Published on 20 Sep 2021
in Antimicrobials, Resistance and Chemotherapy
Review
Published on 15 Jun 2022
in Developmental and Reproductive Toxicology
Original Research
Published on 15 Oct 2020
in Clinical and Diagnostic Microbiology and Immunology
Review
Published on 15 Feb 2018
in Nanobiotechnology
Review
Published on 08 Nov 2018
in Drug Metabolism and Transport
Original Research
Published on 20 Apr 2021
in Biomaterials
Original Research
Published on 04 Jan 2024
in Nanobiotechnology
Systematic Review
Published on 02 Apr 2025
in Ethnopharmacology
Original Research
Published on 12 Jun 2019
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 10 Jun 2021
in Ethnopharmacology
Original Research
Published on 22 Mar 2021
in Veterinary Pharmacology and Toxicology
Original Research
Published on 16 Jan 2024
in Green and Sustainable Chemistry
Review
Published on 09 Jan 2026
in Cancer Immunity and Immunotherapy